WMT AG receives financing with participation from L-Bank’s “InnoGrowth BW” program
Marathon Beteiligungs AG is the lead investor, CARMA Funds also participates in €3.67 million round…
SPRIN-D awards research contract in the field of viral infections and sepsis to WMT AG
WMT tests substances from the “Translational Trap” platform for antiviral and antisepsis effects in cellular assays and animal models…
Pirocco Foundation invests into WMT AG
The Swiss foundation supports WMT´s philosophy of uniting excellent drug discovery skills with the idea of making drugs “affordable for the world”
FS Investment acquires a stake in WMT AG
The Düsseldorf-based family office is particularly impressed by the sustainable research and development approach…